Those drugs are GLP-1 receptor agonists
Instead, we want to provide guidance and information so you can make the best decision
We dive into major updates on retatrutide, new Phase 3 timelines, and why Lilly is positioning next-generation GLP-1 and GIP therapies far beyond obesity, including osteoarthritis, sleep apnea, addiction, and mental health
Lyophilised peptides tolerate short-term ambient exposure better than reconstituted solutions, but anything beyond 72 hours at 25C or 24 hours above 30C likely caused measurable degradation
Hence prognostic scores based on the severity of liver disease and infection, as well as related predictive models, can be used to determine the prognosis of ESLD complicated by infection